CASZ1
Basic information
Region (hg38): 1:10636604-10796650
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Primary dilated cardiomyopathy (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CASZ1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 91 | 29 | 122 | |||
missense | 157 | 15 | 16 | 189 | ||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 13 | 17 | ||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 5 | 5 | 10 | |||
non coding | 15 | 30 | 46 | |||
Total | 2 | 1 | 174 | 124 | 76 |
Variants in CASZ1
This is a list of pathogenic ClinVar variants found in the CASZ1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-10638911-A-AGGCCGC | Benign (May 11, 2021) | |||
1-10638946-G-A | Uncertain significance (Oct 31, 2021) | |||
1-10638951-G-A | Likely benign (Mar 14, 2021) | |||
1-10638954-G-C | Likely benign (Feb 14, 2022) | |||
1-10638962-T-A | not specified | Uncertain significance (Apr 22, 2022) | ||
1-10638979-G-T | Uncertain significance (Jul 31, 2023) | |||
1-10638982-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
1-10638985-A-G | not specified | Uncertain significance (May 11, 2022) | ||
1-10638988-G-C | Uncertain significance (Sep 06, 2023) | |||
1-10638997-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
1-10639009-G-C | Benign (Jan 31, 2024) | |||
1-10639015-C-T | not specified | Uncertain significance (Oct 31, 2021) | ||
1-10639017-C-T | Likely benign (Oct 04, 2023) | |||
1-10639053-C-A | Likely benign (Aug 13, 2022) | |||
1-10639058-A-G | not specified | Uncertain significance (Aug 02, 2022) | ||
1-10639060-T-G | not specified | Uncertain significance (Aug 02, 2022) | ||
1-10639067-A-G | not specified | Uncertain significance (Mar 01, 2023) | ||
1-10639068-G-T | Benign (Jun 06, 2023) | |||
1-10639079-GGTCCTCGTCGTCGTC-G | Uncertain significance (Nov 10, 2021) | |||
1-10639079-GGTCCTCGTCGTCGTCGTCCTCGTCGTC-G | Uncertain significance (Jun 15, 2022) | |||
1-10639083-CTCGTCG-C | Neutrophil inclusion bodies | Benign (Jan 31, 2024) | ||
1-10639083-C-CTCG | Uncertain significance (Jul 02, 2022) | |||
1-10639086-GTCGTCGTCGTCC-G | CASZ1-related disorder | Benign/Likely benign (Nov 01, 2024) | ||
1-10639086-G-GTCGTCGTCGTCC | Uncertain significance (Sep 08, 2023) | |||
1-10639098-CTCGTCGTCGTCCTCG-C | Uncertain significance (Dec 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CASZ1 | protein_coding | protein_coding | ENST00000377022 | 18 | 160047 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 2.10e-7 | 125740 | 0 | 5 | 125745 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.61 | 866 | 1.11e+3 | 0.780 | 0.0000782 | 11414 |
Missense in Polyphen | 387 | 576.91 | 0.67082 | 5772 | ||
Synonymous | 0.499 | 508 | 523 | 0.972 | 0.0000438 | 3571 |
Loss of Function | 6.72 | 4 | 60.3 | 0.0663 | 0.00000293 | 718 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000617 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000268 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator (PubMed:23639441, PubMed:27693370). Involved in vascular assembly and morphogenesis through direct transcriptional regulation of EGFL7 (PubMed:23639441). {ECO:0000269|PubMed:23639441, ECO:0000269|PubMed:27693370}.;
Recessive Scores
- pRec
- 0.275
Intolerance Scores
- loftool
- 0.00200
- rvis_EVS
- -2.42
- rvis_percentile_EVS
- 1.06
Haploinsufficiency Scores
- pHI
- 0.717
- hipred
- Y
- hipred_score
- 0.752
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.532
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Casz1
- Phenotype
- liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;multicellular organism development;positive regulation of transcription, DNA-templated
- Cellular component
- nucleoplasm;cytosol;intracellular membrane-bounded organelle
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding